Related Experiment Video
Updated: Feb 14, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental
Jin Hyoung Kim1, Ju Hyun Shim2, Hyun-Ki Yoon1
1Department of Radiology and Research Institute of Radiology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Insights
Transarterial chemoembolization (TACE) is effective for selected hepatocellular carcinoma (HCC) patients with segmental portal vein tumor thrombosis (PVTT). Four risk factors predict poor survival, suggesting TACE may not be suitable for patients with multiple risk factors.
Area of Science:
- Hepatobiliary Oncology
- Interventional Radiology
- Prognostic Factor Analysis
Background:
- Hepatocellular carcinoma (HCC) with segmental portal vein tumor thrombosis (PVTT) presents a treatment challenge.
- Transarterial chemoembolization (TACE) is a common treatment modality for HCC.
Purpose of the Study:
- To evaluate survival outcomes after TACE in patients with HCC and segmental PVTT.
- To identify independent prognostic factors influencing survival in this patient cohort.
Main Methods:
- Retrospective analysis of 331 patients with HCC and segmental PVTT treated with TACE between 1997 and 2015.
- Multivariable Cox regression analysis to determine prognostic factors for survival.
Main Results:
- Median survival was 10.7 months; 1-, 3-, and 5-year survival rates were 44.9%, 16%, and 12%.
- Objective tumor response to TACE was observed in 53.8% of patients.
- Independent prognostic factors for survival included up-to-11 criteria, extrahepatic metastasis, Child-Pugh class, and tumor response to TACE.
Conclusions:
- TACE is well-tolerated and effective in selected HCC patients with segmental PVTT.
- Major tumor burden, extrahepatic spread, Child-Pugh class B, and lack of tumor regression are associated with decreased survival.
- TACE may not be recommended for patients with 2-4 identified risk factors due to poor survival outcomes.
Background & Aims:
We evaluated survival outcomes and prognostic factors associated with survival after TACE in a large cohort of 331 patients with HCC with segmental PVTT.
Methods:
From 1997 to 2015, a total of 331 patients were included in this study from among 507 patients who underwent TACE as a first-line treatment for HCC with segmental PVTT.
Results:
After TACE, the median survival of the whole cohort was 10.7 months, and the 1-year, 3-year and 5-year survival rates were 44.9%, 16% and 12% respectively. Objective tumour response after TACE was achieved in 53.8% of patients. Multivariable Cox regression analyses confirmed that up-to-11 criteria, extrahepatic metastasis, Child-Pugh class, and tumour response to TACE were independent prognostic factors for patient survival. The expected median survival times among patients with 0, 1 and 2-4 risk factors were 29.1, 15.1 and 5.3 months respectively. The 30-day mortality and major complications rates after TACE were 0.9% and 5.4% respectively.
Conclusions:
TACE was well-tolerated and effective in selected patients with HCC with segmental PVTT. We found that four risk factors were associated with decreased length of patient survival after TACE: a major tumour burden (up-to-11 criteria out), extrahepatic spread, Child-Pugh class B liver function and nonregression to TACE. TACE may not be recommended for HCC patients with segmental PVTT with 2-4 risk factors because of poor survival outcome.
Related Concept Videos
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
What is Natural Selection?
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Veins
Structure of Veins:
The structure of veins is specifically designed to assist in the low-pressure transportation of...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...

